Profiling the Peripheral Blood Immune Cell Repertoire in Large-B Cell Lymphoma Patients Treated with CD19 CAR-T
Giulia Cheloni(Tumour Institute of Tuscany), Ioannis S. Vlachos(Broad Institute), Mike Mattie, Eleni Kanata(Broad Institute), David Avigan(Beth Israel Deaconess Medical Center), Jacalyn Rosenblatt(Beth Israel Deaconess Medical Center), Adrian Bot(Alliance Pharmaceutical (United States)), Yered Pita-Juárez(Broad Institute), Justin Chou, Dina Stroopinsky(Beth Israel Deaconess Medical Center), Poorva Bindal(Beth Israel Deaconess Medical Center), Daniela Torres(Beth Israel Deaconess Medical Center), Anita G. Koshy(Beth Israel Deaconess Medical Center), Jessica J. Liegel(Beth Israel Deaconess Medical Center), Dimitra Karagkouni(University of Thessaly)
Cited by 1
Related Papers
DIANA-miRPath v3.0: deciphering microRNA function with experimental support
|Nucleic Acids Research|2015|1.8k
Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma
|New England Journal of Medicine|2019|1.7k
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility
|Science|2019|1.4k
DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA–gene interactions
|Nucleic Acids Research|2017|1.2k
DIANA-microT web server v5.0: service integration into miRNA functional analysis workflows
|Nucleic Acids Research|2013|1.2k